Publications by authors named "Grace Gilmore"

Claim this Profile
A
A Randomized, Open-Label Trial to Assess Feasibility and Tolerability of Topical Cannabis Balms for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS).
Dylan Zylla, Dame Idossa, Maria Borrero, Char Napurski, Stephen Dahmer, Grace Gilmore

Cannabis Cannabinoid Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study.
Ross I Baker, Grace Gilmore, Vivien Chen, Laura Young, Eileen Merriman

Res Pract Thromb Haemost· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic Leukemia.
Omar Elaskalani, Grace Gilmore, Madison Hagger, Ross I Baker, Pat Metharom

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports.
Jordan Guggisberg, Megan Schumacher, Grace Gilmore, Dylan M Zylla

Cannabis Cannabinoid Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction.
Dylan M Zylla, Justin Eklund, Grace Gilmore, Alissa Gavenda, Jordan Guggisberg

Support Care Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estradiol-Responsive miR-365a-3p Interacts with Tissue Factor 3'UTR to Modulate Tissue Factor-Initiated Thrombin Generation.
Jiayin Tian, Murray J Adams, Jasmine Wee Ting Tay, Ian James, Suzanne Powell, Grace Gilmore

Thromb Haemost· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer.
Grant L Steele, Arkadiusz Z Dudek, Grace E Gilmore, Sara A Richter, Douglas A Olson

Am J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collection of electronic patient-reported symptoms in patients with advanced cancer using Epic MyChart surveys.
Dylan M Zylla, Grace E Gilmore, Grant L Steele, Justin P Eklund, Christina M Wood

Support Care Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference.
Emmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, Elysse Dean, Sandya Arunachalam

Clin Chem Lab Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects.
Emmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, Elysse Dean, Sandya Arunachalam

Haemophilia· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa.
Emmanuel J Favaloro, Grace Gilmore, Sandya Arunachalam, Soma Mohammed, Ross Baker

Thromb Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy.
Dylan Zylla, Grace Gilmore, Justin Eklund, Sara Richter, Anders Carlson

J Diabetes Complications· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating MicroRNA as Thrombosis Sentinels: Caveats and Considerations.
Jasmine Tay, Jim Tiao, Quintin Hughes, Jessica Jorritsma, Grace Gilmore

Semin Thromb Hemost· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties.
Quintin W Hughes, Bao T Le, Grace Gilmore, Ross I Baker, Rakesh N Veedu

Molecules· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tissue factor pathway in ischemic stroke.
Murray J Adams, Jim Thom, Graeme J Hankey, Ross Baker, Grace Gilmore

Blood Coagul Fibrinolysis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
Jim Thom, Leesa Ivey, Grace Gilmore, John W Eikelboom

Blood Coagul Fibrinolysis· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
Emmanuel J Favaloro, Melinda Bukuya, Teresa Martinelli, Joanne Tzouroutis, Elizabeth Duncan, Grace Gilmore

Thromb Haemost· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis